Gilead Sciences (GILD) Enterprise Value Growth (1y) (2010 - 2026)

Gilead Sciences (GILD) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.53%
Dec 31, 2025 23.41%
Sep 30, 2025 -45.15%
Jun 30, 2025 -85.47%
Mar 31, 2025 -66.81%
Dec 31, 2024 -37.11%
Sep 30, 2024 26.17%
Jun 30, 2024 57.57%
Mar 31, 2024 19.02%
Dec 31, 2023 -14.53%
Sep 30, 2023 -22.03%
Jun 30, 2023 -18.42%
Mar 31, 2023 -11.11%
Dec 31, 2022 1.67%
Sep 30, 2022 0.92%
Jun 30, 2022 12.80%
Mar 31, 2022 5.61%
Dec 31, 2021 11.69%
Sep 30, 2021 76.04%
Jun 30, 2021 65.33%